ABOUT US
Established in Dec 2010 , PRADO Preclinical Research and Development Organisation Private Limited is one of India’s fastest-growing and well-established preclinical CRO. It has gained outstanding reputation for providing high-quality, globally-benchmarked, reliable and cost-effective services for both domestic and international clients.
The scientific data and reports from PRADO have an excellent acceptance record with regulatory agencies and have facilitated the smooth and timely product registrations and regulatory approvals for clients.
PRADO, the GLP-certified, CPCSEA and DSIR approved preclinical research facility is spread over 12,500 sqft at Urse, near Pune in India. It is equipped with several modern analytical and testing equipment that are critical for high-quality testing and analysis.
PRADO’s technical, research and development services are specifically designed and targeted to support the pharmaceutical, biopharma & biotech (including vaccines and stem cells), agrochemical, medical devices and animal health sectors, as well as the academic and R&D community.
The overarching aim of PRADO’s services is to help these industries and associated institutions to effectively manage their journeys towards the regulatory approval of their discovery as well as new product development programs. PRADO team Has all the necessary expertise to work closely with client team for generating all the data and information required for timely regulatory submissions and preparing for other requirements.
PRADO constantly endeavours to be a trusted strategic partner for industry by bringing to the table key professionalism attributes – Quality, Timeliness, Integrity and Flexibility.
THE LEADERSHIP/ MANAGEMENT TEAM
Dr. Pralhad
Wangikar
His key research expertise is in the areas of toxicologic pathology including systemic, reproductive and genetic toxicity studies; toxicological risk assessments such as PDE, OEL, AI; development of animal models, clinical and histopathology evaluation.
In addition, Dr. Pralhad Wangikar also has expertise in industry forecasting and consulting for designing state-of-art animal research facilities, GLP certification to various other organizations.
Apart from a regular speaker at industry events, academic gatherings and student interactions he is also a member of board of studies, institutional ethical committee.
At PRADO, Dr. Pralhad Wangikar is a Founder-Director and a CEO. Besides business development and oversight of all study-related operations, he is a designated Test Facility Manager for the GLP-certified Urse facility. Dr. Pralhad Wangikar has co-authored and published several books and scholarly articles on the subject of toxicology as well as on business risk and quality management matters.
At PRADO, Ms. Ila Wangikar is a Founder and Managing Director has been instrumental in PRADO’s development. In this role, she is responsible for all Finance, HR and Administration functions.
Ms. iLa Wangikar
Dr. Pradeep
Deshmukh
Dr. Pradeep Deshmukh is a CRO-industry veteran and has several decades of research and quality management experience with some of the leading CROs in India.
At PRADO, Dr. Pradeep Deshmukh is a designated deputy test facility manager for the GLP-certified Urse facility and is responsible for overseeing the quality-assurance aspects of various study plans. He is also involved in designing and running of GLP-mandated training programs for staff.
THE LEADERSHIP/ MANAGEMENT TEAM
Dr. PRALHAD WANGIKAR
His key research expertise is in the areas of toxicologic pathology including systemic, reproductive and genetic toxicity studies; toxicological risk assessments such as PDE, OEL, AI; development of animal models, clinical and histopathology evaluation.
In addition, Dr. Pralhad Wangikar also has expertise in industry forecasting and consulting for designing state-of-art animal research facilities, GLP certification to various other organizations.
Apart from a regular speaker at industry events, academic gatherings and student interactions he is also a member of board of studies, institutional ethical committee.
At PRADO, Dr. Pralhad Wangikar is a Founder-Director and a CEO. Besides business development and oversight of all study-related operations, he is a designated Test Facility Manager for the GLP-certified Urse facility. Dr. Pralhad Wangikar has co-authored and published several books and scholarly articles on the subject of toxicology as well as on business risk and quality management matters.
Ms. ILA WANGIKAR
Ms. Ila Wangikar first qualified in the area of Commerce and Economics has spent several years donning numerous entrepreneurial hats in the fields of fashion design and garmenting. She has been a keen and avid campion of women’s right to work and financial freedom and has strived to include women in all the projects that she has been associated with.
At PRADO, Ms. Ila Wangikar is a Founder and Managing Director has been instrumental in PRADO’s development. In this role, she is responsible for all Finance, HR and Administration functions.
Dr. PRADEEP DESHMUKH
Dr. Pradeep Deshmukh is a CRO-industry veteran and has several decades of research and quality management experience with some of the leading CROs in India.
At PRADO, Dr. Pradeep Deshmukh is a designated deputy test facility manager for the GLP-certified Urse facility and is responsible for overseeing the quality-assurance aspects of various study plans. He is also involved in designing and running of GLP-mandated training programs for staff.